超6亿,复星子公司将实施A轮融资

动脉网
Oct 19

复星医药发布公告,深圳生物医药产业基金拟参与控股子公司复星凯瑞A轮融资,拟分期出资6亿元认缴其不超过5.24亿元新增注册资本。同时,包括复星凯瑞现任董事及核心管理层在内的14名跟投参与方拟出资352.50万元认缴其308.11万元新增注册资本,因包含公司关联方,构成关联交易。全数实施后,集团持有复星凯瑞股权比例将由约97.7778%降至约77.0977%,其仍为控股子公司。截至2024年12月31...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10